Amelie Harle on Aprepitant's Effectiveness in Treating Cough in Lung Cancer

Article

Amelie Harle, an oncologist at Christie Hospital in Manchester, United Kingdom, discusses the possibility of using aprepitant (Emend) to treat cough in patients with lung cancer.

Amelie Harle, an oncologist at Christie Hospital in Manchester, United Kingdom, discusses the possibility of using aprepitant (Emend) to treat cough in patients with lung cancer.

Harle said that there are few, if any, evidence-based treatments to treat cough for these patients, so she did a study involving 20 people with lung cancer. She noticed that aprepitant did, in fact, reduce cough frequency because it targets the NK-1 pathway, which, in animal studies, was proven to effect cough.

Since her study was small, Harle said that the next step would be a larger and longer study, with two groups of patients: one receiving aprepitant, and the other receiving a placebo to see the true effectiveness of the drug.

Related Videos
Elizabeth Aronson
MPN-Associated Anemia: What Nurses Should Look Out For
Cancer-Related Cognitive Impairment
Charina Toste
Lindsey Lyle
Alyssa Ridad
Yelena Shames
Johanna Garibaldi
Elizabeth Cullen
Related Content
© 2023 MJH Life Sciences

All rights reserved.